| 1 | [SID85201105] | Active | AC50 | 1.096 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | AC50 | 1.096 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID85201105] | Active | AC50 | 1.877 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | AC50 | 1.877 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID85201105] | Active | Potency | 2.9093 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | Potency | 2.9093 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 4 | [SID85201105] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID85201105] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID85201105] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID85201105] | Active | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | Il2 gene product [Mus musculus] [gi:7110653] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | Il2 gene product [Mus musculus] [gi:7110653] | | PubMed | | | Data Table |  |
|
| 8 | [SID85201105] | Active | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 9 | [SID85201105] | Active | | | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay [AID504720, Type: screening] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay | | AID | 504720 | | BioAssay type | screening | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|
| 10 | [SID85201105] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 11 | [SID85201105] | Active | | | Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA) [AID624371, Type: screening] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA) | | AID | 624371 | | BioAssay type | screening | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 12 | [SID85201105] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID504383, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 504383 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 13 | [SID85201105] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493008, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493008 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 14 | [SID85201105] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID85201105] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity [AID588334, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity | | AID | 588334 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID85201105] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 17 | [SID85201105] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 18 | [SID85201105] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 19 | [SID85201105] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 20 | [SID85201105] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624370, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624370 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 21 | [SID85201105] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624370, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624370 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 22 | [SID85201105] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 23 | [SID85201105] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 24 | [SID85201105] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 25 | [SID85201105] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 26 | [SID85201105] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID492963, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 492963 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 27 | [SID85201105] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID492963, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 492963 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 28 | [SID85201105] | Active | | | Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID492964, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 492964 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 29 | [SID85201105] | Active | | | Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID492964, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Active | | BioAssay | Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 492964 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 30 | [SID85201105] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 31 | [SID85201105] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 32 | [SID85201105] | Inactive | Potency | 2.5119 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | Potency | 2.5119 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID85201105] | Inactive | Potency | 3.1623 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 34 | [SID85201105] | Inactive | Potency | 17.7828 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 35 | [SID85201105] | Inactive | Potency | 17.7828 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 36 | [SID85201105] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID85201105] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 38 | [SID85201105] | Inactive | Potency | 63.0957 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | Potency | 63.0957 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 39 | [SID85201105] | Inactive | EC50 | 82.9 | Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay counterscreen [AID588502, Type: confirmatory] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | EC50 | 82.9 [uM] | | BioAssay | Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay counterscreen | | AID | 588502 | | BioAssay type | confirmatory | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|
| 40 | [SID85201105] | Inactive | EC50 | 99 | Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay [AID588481, Type: confirmatory] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | EC50 | 99 [uM] | | BioAssay | Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay | | AID | 588481 | | BioAssay type | confirmatory | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|
| 41 | [SID85201105] | Inactive | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493244, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493244 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 42 | [SID85201105] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase [AID602233, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase | | AID | 602233 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 43 | [SID85201105] | Inactive | | | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction [AID2629, Type: screening] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 2629 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 44 | [SID85201105] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set [AID588499, Type: Literature] | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | | AID | 588499 | | BioAssay type | Literature | | Target | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] | | PubMed | 16604538 | | Data Table |  |
|
| 45 | [SID85201105] | Inactive | | | Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity [AID488965, Type: screening] | pvdQ gene product [Pseudomonas aeruginosa LESB58] [gi:218891639] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488965 | | BioAssay type | screening | | Target | pvdQ gene product [Pseudomonas aeruginosa LESB58] [gi:218891639] | | PubMed | | | Data Table |  |
|
| 46 | [SID85201105] | Inactive | | | Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity [AID602481, Type: screening] | bioA [Mycobacterium tuberculosis UT205] [gi:378544807] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602481 | | BioAssay type | screening | | Target | bioA [Mycobacterium tuberculosis UT205] [gi:378544807] | | PubMed | | | Data Table |  |
|
| 47 | [SID85201105] | Inactive | | | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity [AID588549, Type: screening] | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588549 | | BioAssay type | screening | | Target | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] | | PubMed | | | Data Table |  |
|
| 48 | [SID85201105] | Inactive | | | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex [AID435030, Type: screening] | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex | | AID | 435030 | | BioAssay type | screening | | Target | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] | | PubMed | | | Data Table |  |
|
| 49 | [SID85201105] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) [AID602123, Type: screening] | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) | | AID | 602123 | | BioAssay type | screening | | Target | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] | | PubMed | | | Data Table |  |
|
| 50 | [SID85201105] | Inactive | | | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity [AID488895, Type: screening] | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 85201105 | | CID | 44202190 | | Outcome | Inactive | | BioAssay | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488895 | | BioAssay type | screening | | Target | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] | | PubMed | | | Data Table |  |
|